Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karie Runcie

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|April 11, 2024
Management of Oligometastatic and Locally Recurrent Urothelial CarcinomaMichael A Liu, Jennifer W Li, Karie Runcie
Translational Cancer Research|December 19, 2024
Adjuvant therapy in renal cell carcinoma (RCC): progress, at lastAndrew N Bueno, Mark N Stein, Karie Runcie
Molecular Medicine (Cambridge, Mass.)|September 26, 2018
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeuticsKarie Runcie, Daniel R Budman, Veena John, et al.
Journal of Cancer Immunology|July 15, 2025
Second-Line Systemic Therapies in Metastatic Renal Cell Carcinoma: Current Insights and Future DirectionsIsaac E Kim, Vivian Wong, Karie Runcie, et al.
Cancer Reports (Hoboken, N.J.)|February 12, 2026
Positive Psychology Interventions in Patients With Prostate Cancer: A Systematic ReviewEleanor Xu, Quan H Phung, Karie Runcie, et al.
Current Opinion in Oncology|May 25, 2023
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinomaTaylor Goodstein, Yuanquan Yang, Karie Runcie, et al.
Journal of Kidney Cancer and VHL|October 4, 2023
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging MalignancyJake Drobner, Daniella Portal, Karie Runcie, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2023
State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell CarcinomaShawn Dason, Kristine Lacuna, Raquibul Hannan, et al.
Targeted Oncology|June 1, 2026
Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?Michael A Liu, Kyle Miyazaki, Karie Runcie, et al.
Expert Review of Anticancer Therapy|April 14, 2026
Clinical management of oligoprogressive renal cell carcinomaEzra Bernstein, Jonathan Schoenhals, Shawn Dason, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|April 11, 2024
Management of Oligometastatic and Locally Recurrent Urothelial CarcinomaMichael A Liu, Jennifer W Li, Karie Runcie
Translational Cancer Research|December 19, 2024
Adjuvant therapy in renal cell carcinoma (RCC): progress, at lastAndrew N Bueno, Mark N Stein, Karie Runcie
Molecular Medicine (Cambridge, Mass.)|September 26, 2018
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeuticsKarie Runcie, Daniel R Budman, Veena John, et al.
Journal of Cancer Immunology|July 15, 2025
Second-Line Systemic Therapies in Metastatic Renal Cell Carcinoma: Current Insights and Future DirectionsIsaac E Kim, Vivian Wong, Karie Runcie, et al.
Cancer Reports (Hoboken, N.J.)|February 12, 2026
Positive Psychology Interventions in Patients With Prostate Cancer: A Systematic ReviewEleanor Xu, Quan H Phung, Karie Runcie, et al.
Current Opinion in Oncology|May 25, 2023
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinomaTaylor Goodstein, Yuanquan Yang, Karie Runcie, et al.
Journal of Kidney Cancer and VHL|October 4, 2023
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging MalignancyJake Drobner, Daniella Portal, Karie Runcie, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2023
State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell CarcinomaShawn Dason, Kristine Lacuna, Raquibul Hannan, et al.
Targeted Oncology|June 1, 2026
Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?Michael A Liu, Kyle Miyazaki, Karie Runcie, et al.
Expert Review of Anticancer Therapy|April 14, 2026
Clinical management of oligoprogressive renal cell carcinomaEzra Bernstein, Jonathan Schoenhals, Shawn Dason, et al.
Pageof 2